Facebook
Twitter
Telegram
Report an ErrorSyros Pharmaceuticals Financial Statements 2011-2024 | SYRS
Annual Financial Statements Syros Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
165 M | 46 M | 8.07 M | 38.7 M | 282 M | 185 M | 266 M | 136 M | - | - | - | - | - |
Shares |
28.3 M | 12.6 M | 6.25 M | 4.61 M | 40.2 M | 32.7 M | 25.4 M | 12.7 M | - | - | - | - | - |
Historical Prices |
5.84 | 3.64 | 1.29 | 8.4 | 5.85 | 6.79 | 10.5 | 11.1 | - | - | - | - | - |
Net Income |
-165 M | -94.7 M | -86.6 M | -84 M | -75.4 M | -62.3 M | -54 M | -47.7 M | -29.8 M | -13.4 M | - | - | - |
Revenue |
9.94 M | 14.9 M | 23.5 M | 15.1 M | 1.98 M | 2.05 M | 1.1 M | 317 K | 317 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-129 M | -136 M | -99.4 M | -82.3 M | -77.7 M | -64.3 M | -54.7 M | -48 M | -29.8 M | -13.4 M | - | - | - |
Interest Expense |
5.13 M | 4.13 M | 3.91 M | 1.79 M | 72 K | 1 K | 676 K | 220 K | 2 K | 4 K | - | - | - |
EBITDA |
-127 M | -133 M | -96.7 M | -79.5 M | -75 M | -62.7 M | -53.2 M | -46.7 M | -29.2 M | -13.2 M | - | - | - |
Operating Expenses |
139 M | 151 M | 123 M | 97.4 M | 79.7 M | 66.3 M | 55.8 M | 48.3 M | - | - | - | - | - |
General and Administrative Expenses |
28.3 M | 29.3 M | 23 M | 21.3 M | 21.5 M | 16.2 M | 13.9 M | 10.5 M | 5.73 M | 2.51 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Syros Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
39 M | 26.4 M | 28 M | 27.9 M | 27.8 M | 20.3 M | 9.42 M | 6.38 M | 6.31 M | 6.2 M | 6.29 M | 62.9 M | 61.4 M | 48.8 M | 45.8 M | 45.7 M | 43.9 M | 42.9 M | 42.4 M | 41.7 M | 33.8 M | 33.7 M | 33.7 M | 32.9 M | 30.3 M | 26.3 M | 26.3 M | 25.6 M | 23.4 M | 23.4 M | 22 M | 2.55 M | 2.39 M | 2.32 M | 2.15 M | 1.76 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-3.71 M | - | -40.1 M | -36.3 M | -23.8 M | - | -30.3 M | -34.5 M | -25.1 M | - | -26 M | -22.5 M | -14.2 M | -30.1 M | -84 M | -84 M | -84 M | -19.7 M | -75.4 M | -75.4 M | -75.4 M | -18 M | -62.3 M | -62.3 M | -62.3 M | -15.3 M | -54 M | -54 M | -54 M | -11 M | -47.7 M | -47.7 M | -47.7 M | -10.7 M | -29.8 M | -29.8 M | -4.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | 3.76 M | 2.83 M | 2.95 M | - | 3.89 M | 6.28 M | 5.47 M | - | 5.7 M | 5.16 M | 4.83 M | 5.7 M | 3.83 M | 3.19 M | 2.38 M | 508 K | 558 K | 462 K | 454 K | 893 K | 412 K | 375 K | 370 K | - | 1.1 M | 1.1 M | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-30.9 M | - | -34.6 M | -34 M | -33.2 M | - | -39.5 M | -33.8 M | -26.7 M | - | -26.9 M | -26.1 M | -20.9 M | -29.2 M | -19 M | -16.7 M | -17.3 M | -20.2 M | -20.4 M | -20.2 M | -17 M | -18.6 M | -16.3 M | -14.5 M | -14.8 M | -15.5 M | -14 M | -13.5 M | -11.6 M | -11 M | -14.2 M | -12.1 M | -10.6 M | -10.7 M | -8.46 M | -6.1 M | -4.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.31 M | - | 1.3 M | 1.28 M | 1.22 M | - | 1.05 M | 981 K | 976 K | - | 984 K | 969 K | 967 K | 541 K | 493 K | 487 K | 271 K | 20 K | 21 K | 23 K | 8 K | 575 K | 583 K | 501 K | 358 K | 218 K | 215 K | 145 K | 98 K | 80 K | 48 K | 44 K | 48 K | - | 2 K | -2 K | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-30.6 M | - | - | - | -32.6 M | - | -37.5 M | -32.4 M | -26 M | - | -24.9 M | -24.8 M | -20.3 M | -29.2 M | -16.9 M | -15.4 M | -16.7 M | -20.2 M | -18.7 M | -19.1 M | -16.5 M | -18.6 M | -15.1 M | -13.8 M | -14.4 M | -15.5 M | -12.9 M | -12.8 M | -11.2 M | -11 M | -13.3 M | -11.4 M | -10.3 M | -10.7 M | -8.09 M | -5.91 M | -4.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
30.9 M | - | 38.4 M | 36.8 M | 36.2 M | - | 43.3 M | 40 M | 32.1 M | - | 32.6 M | 31.3 M | 25.8 M | 34.9 M | 22.8 M | 19.9 M | 19.7 M | 20.7 M | 20.9 M | 20.7 M | 17.4 M | 19.5 M | 16.7 M | 14.9 M | 15.2 M | 15.5 M | 14 M | 13.5 M | 12.7 M | 11.4 M | 14.2 M | 12.1 M | 10.6 M | 10.7 M | 8.46 M | 6.41 M | 4.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.27 M | - | 7.76 M | 7.22 M | 7.4 M | - | 8.08 M | 6.94 M | 6.95 M | - | 5.35 M | 5.52 M | 5.74 M | 5.89 M | 5.15 M | 5.13 M | 5.15 M | 6.4 M | 5.02 M | 5.2 M | 4.86 M | 4.37 M | 3.88 M | 3.84 M | 4.08 M | 3.74 M | 3.59 M | 3.47 M | 3.09 M | 2.92 M | 2.63 M | 2.54 M | 2.37 M | 2.31 M | 1.6 M | 984 K | 836 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency